These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 8555981

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
    Albrechet-Souza L, Oliveira AR, De Luca MC, Tomazini FM, Santos NR, Brandão ML.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
    [Abstract] [Full Text] [Related]

  • 5. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity.
    Albrechet-Souza L, Borelli KG, Carvalho MC, Brandão ML.
    Neuroscience; 2009 Dec 01; 164(2):387-97. PubMed ID: 19699782
    [Abstract] [Full Text] [Related]

  • 6. Ethopharmacological analysis of rat behavior on the elevated plus-maze.
    Cruz AP, Frei F, Graeff FG.
    Pharmacol Biochem Behav; 1994 Sep 01; 49(1):171-6. PubMed ID: 7816869
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of the elevated plus-maze test with opaque or transparent walls in the detection of mouse strain differences and the anxiolytic effects of diazepam.
    Hagenbuch N, Feldon J, Yee BK.
    Behav Pharmacol; 2006 Feb 01; 17(1):31-41. PubMed ID: 16377961
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of rat behavior in the elevated plus-maze using a directed graph.
    Tejada J, Bosco GG, Morato S, Roque AC.
    J Neurosci Methods; 2009 Nov 15; 184(2):251-5. PubMed ID: 19699234
    [Abstract] [Full Text] [Related]

  • 17. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S, File SE.
    Pharmacol Biochem Behav; 1986 Mar 15; 24(3):525-9. PubMed ID: 2871560
    [Abstract] [Full Text] [Related]

  • 18. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
    Mendes-Gomes J, Nunes-de-Souza RL.
    Brain Res; 2005 Jun 14; 1047(1):97-104. PubMed ID: 15893297
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1.
    Dal-Cól ML, Pereira LO, Rosa VP, Calixto AV, Carobrez AP, Faria MS.
    Pharmacol Biochem Behav; 2003 Jan 14; 74(2):395-400. PubMed ID: 12479960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.